About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Discover New Drug Target for Schizophrenia

by Sheela Philomena on August 14, 2012 at 11:56 AM
Font : A-A+

 Researchers Discover New Drug Target for Schizophrenia

Novel drug target for schizophrenia - devastating mental illness has been identified by researchers.

The study will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.

Advertisement

A team of researchers at Mount Sinai School of Medicine set out to discover what epigenetic factors, or external factors that influence gene expression, are involved in this treatment-resistance to atypical antipsychotic drugs, the standard of care for schizophrenia.

They discovered that, over time, an enzyme in the brains of schizophrenic patients analysed at autopsy begins to compensate for the prolonged chemical changes caused by antipsychotics, resulting in reduced efficacy of the drugs.
Advertisement

"These results are groundbreaking because they show that drug resistance may be caused by the very medications prescribed to treat schizophrenia, when administered chronically," said Javier Gonzalez-Maeso, PhD, Assistant Professor of Psychiatry and Neurology at Mount Sinai School of Medicine and lead investigator on the study.

They found that an enzyme called HDAC2 was highly expressed in the brain of mice chronically treated with antipsychotic drugs, resulting in lower expression of the receptor called mGlu2, and a recurrence of psychotic symptoms.

A similar finding was observed in the postmortem brains of schizophrenic patients.

The research team administered a chemical called suberoylanilide hydroxamic acid (SAHA), which inhibits the entire family of HDACs. They found that this treatment prevented the detrimental effect of the antipsychotic called clozapine on mGlu2 expression, and also improved the therapeutic effects of atypical antipsychotics in mouse models.

Previous research conducted by the team showed that chronic treatment with the antipsychotic clozapine causes repression of mGlu2 expression in the frontal cortex of mice, a brain area key to cognition and perception.

The researchers hypothesized that this effect of clozapine on mGlu2 may play a crucial role in restraining the therapeutic effects of antipsychotic drugs.

"We had previously found that chronic antipsychotic drug administration causes biochemical changes in the brain that may limit the therapeutic effects of these drugs," Dr. Gonzalez-Maeso said.

"We wanted to identify the molecular mechanism responsible for this biochemical change, and explore it as a new target for new drugs that enhance the therapeutic efficacy of antipsychotic drugs," Dr. Gonzalez-Maeso said.

"We found that atypical antipsychotic drugs trigger an increase of HDAC2 in frontal cortex of individuals with schizophrenia, which then reduces the presence of mGlu2, and thereby limits the efficacy of these drugs," Mitsumasa Kurita, PhD, a postdoctoral fellow at Mount Sinai and the lead author of the study, said.

The study was recently published online in Nature Neuroscience.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Schizophrenia Clinical Trials - Different Phases of the trial Signature Drug Toxicity 

Most Popular on Medindia

Indian Medical Journals Sinopril (2mg) (Lacidipine) Blood Pressure Calculator Blood Donation - Recipients Drug - Food Interactions Daily Calorie Requirements Selfie Addiction Calculator Iron Intake Calculator Hearing Loss Calculator Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use